Indication
Spinocerebellar Ataxia Genotype Type 3
1 clinical trial
2 products
Product
TroriluzoleClinical trial
A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult Subjects With Spinocerebellar AtaxiaStatus: Active (not recruiting), Estimated PCD: 2017-08-18
Product
Placebo